Summary
The role of methyl-CpG binding domain protein 2 (MBD2) in an ApoE-deficient mouse model of age-related macular degeneration (AMD) was investigated. Eight-week-old Mbd2/ApoE double deficient (Mbd2-/- ApoE-/-) mice (n=12, 24 eyes, experimental group) and MBD2 (wt) ApoE-/- mice (n=12, 24 eyes, control group) were fed on Western-type diet for 4 months. The mice were sacrificed, and total serum cholesterol levels were analyzed and Bruch’s membrane (BM) of the eyes was removed for ultrastructural observation by transmission electron microscopy. Moreover, intercellular adhesion molecule 1 (ICAM-1) immunoreactivities were evaluated by fluorescence microscopy in sections of the eyes in both groups for further understanding the function mechanism of MBD2. There was no significant difference in the total serum cholesterol levels between control group and experimental group (P>0.05). Transmission electron microscopy revealed that AMD-like lesions, various vacuoles accumulated on BM, notable outer collagenous layer deposits and dilated basal infoldings of retinal pigment epithelium (RPE) were seen in both groups, and the BM in control group was significantly thickened as compared with experimental group (P<0.05). Fluorescence micrographs exhibited the expression of ICAM-1 in choroid was higher in control group than in experimental group. We are led to conclude that MBD2 gene knockout may lead to accumulation of more deposits on the BM and influence the pathogenesis of AMD via triggering endothelial activation and inflammatory response in choroid, improving microcirculation, and reducing lipid deposition so as to inhibit the development of AMD-like lesions. Our study helps to provide a new therapeutic approach for the clinical treatment of AMD.
Similar content being viewed by others
References
Lim LS, Mitchell P, Seddon JM, et al. Age-related macular degeneration. Lancet, 2012, 379(9827):728–1738
Zarbin MA. In: Bandello F, Querques G, eds. Medical Retina. Basel: Karger, 2012:125–133
Gorin MB. Genetic insights into age-related macular degeneration: controversies addressing risk, causality, and therapeutics. Mol Aspects Med, 2012, 33(4):467–486
Wang Y, Wang VM, Chan CC. The role of anti-inflammatory agents in age-related macular degeneration (AMD) treatment. Eye (Lond) 2011, 25(2): 127–139
Miao H, Tao Y, Li XX, et al. Inflammatory cytokines in aqueous humor of patients with choroidal neovascularization. Mol Vis, 2012, 18, 574–580
Skeie JM, Hernandez J, Hinek A, et al. Molecular responses of choroidal endothelial cells to elastin derived peptides through the elastin-binding protein (GLB1). Matrix Biol, 2012, 31(2):113–119
Switzer DW Jr, Mendonca LS, Saito M, et al. Segregation of ophthalmoscopic characteristics according to choroidal thickness in patients with early age-related macular degeneration. Retina, 2012, 32(7):265–271
Dimitrova G, Kato S. Color Doppler imaging of retinal diseases. Surv Ophthalmol, 2010, 55(3):193–214
Dawson MA, Kouzarides T. Cancer epigenetics: from mechanism to therapy. Cell, 2012, 150(1):12–27
Godfrey KM, Sheppard A, Gluckman PD, et al. Epigenetic gene promoter methylation at birth is associated with child’s later adiposity. Diabetes, 2011, 60(5):1528–1534
Udali S, Guarini P, Moruzzi S, et al. Cardiovascular epigenetics: From DNA methylation to microRNAs. Mol Aspects Med, 2013, 34(4):883–901
Cvekl A, Mitton KP. Epigenetic regulatory mechanisms in vertebrate eye development and disease. Heredity (Edinb), 2010, 105(1):135–151
Zhou P, Luo Y, Liu X, et al. Down-regulation and CpG island hypermethylation of CRYAA in age-related nuclear cataract. FASEB J, 2012, 26(12):4897–4902
Wiggs JL. The cell and molecular biology of complex forms of glaucoma: updates on genetic, environmental, and epigenetic risk factors. Invest Ophthalmol Vis Sci, 2012, 53(5):2467–2469
Zhong Q, Kowluru RA. Epigenetic changes in mitochondrial superoxide dismutase in the retina and the development of diabetic retinopathy. Diabetes, 2011, 60(4):1304–1313
Yin X, Latif R, Bahn RS, et al. Genetic profiling in graves’ disease: further evidence for lack of a distinct genetic contribution to Graves’ ophthalmopathy. Thyroid, 2012, 22(7):730–736
Temming P, Corson TW, Lohmann DR, et al. Retinoblastoma tumorigenesis: genetic and epigenetic changes walk hand in hand. Future Oncol, 2012, 8(5): 525–528
Suuronen T, Nuutinen T, Ryhanen T, et al. Epigenetic regulation of clusterin/apolipoprotein J expression in retinal pigment epithelial cells. Biochem Biophys Res Commun, 2007, 357(2):397–401
Hunter A, Spechler PA, Cwanger A, et al. DNA methylation is associated with altered gene expression in AMD. Invest Ophthalmol Vis Sci, 2012, 53(4):2089–2105
Rao X, Zhong J, Zhang S, et al. Loss of methyl-CpG-binding domain protein 2 enhances endothelial angiogenesis and protects mice against hind-limb ischemic injury. Circulation, 2011, 123(25): 2964–2974
Mares-Perlman JA, Brady WE, Klein R, et al. Dietary fat and age-related maculopathy. Arch Ophthalmol, 1995, 113(6): 743–748
Sin HP, Liu DT, Lam DS, et al. Lifestyle modification, nutritional and vitamins supplements for age-related macular degeneration. Acta Ophthalmol, 2013, 91(1):6–11
Weikel KA, Chiu CJ, Taylor A, et al. Nutritional modulation of age-related macular degeneration. Mol Aspects Med, 2012, 33(4):318–375
Wong IY, Koo SC, Chan CW, et al. Prevention of age-related macular degeneration. Int Ophthalmol, 2011, 31(1):73–82
Nakashima Y, Plump AS, Raines EW, et al. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb Vasc Biol, 1994, 14(1):133–140
Malek G, Johnson LV, Mace BE, et al. Apolipoprotein E allele-dependent pathogenesis: a model for age-related retinal degeneration. Proc Natl Acad Sci U S A, 2005, 102(33):1900–11905
Bhutto I, Lutty G. Understanding age-related macular degeneration (AMD): relationships between the photoreceptor/retinal pigment epithelium/Bruch’s membrane/choriocapillaris complex. Mol Aspects Med, 2012, 33(4):295–317
Kozlowski MR. RPE cell senescence: a key contributor to age-related macular degeneration. Med Hypotheses, 2012, 78(4):505–510
Mettu PS, Wielgus AR, Ong SS, et al. Retinal pigment epithelium response to oxidant injury in the pathogenesis of early age-related macular degeneration. Mol Aspects Med, 2012, 33(4):376–398
Hussain AA, Lee Y, Zhang JJ, et al. Disturbed matrix metalloproteinase activity of Bruch’s membrane in age-related macular degeneration. Invest Ophthalmol Vis Sci, 2011, 52(7):4459–4466
Ong JM, Zorapapel NC, Rich KA, et al. Effects of cholesterol and apolipoprotein E on retinal abnormalities in ApoE-deficient mice. Invest Ophthalmol Vis Sci, 2001, 42(8):1891–1900
Pennesi ME, Neuringer M, Courtney RJ, et al. Animal models of age related macular degeneration. Mol Aspects Med, 2012, 33(4):487–509
Dithmar S, Curcio CA, Le NA, et al. Ultrastructural changes in Bruch’s membrane of apolipoprotein E-deficient mice. Invest Ophthalmol Vis Sci, 2000, 41(8): 2035–2042
Ida H, Ishibashi K, Reiser K, et al. Ultrastructural aging of the RPE-Bruch’s membrane-choriocalpilaris complex in the D-galactose-treated mouse. Invest Ophthalmol Vis Sci, 2004, 45(7):2348–2354
Mullins RF, Johnson MN, Faidley EA, et al. Choriocapillaris vascular dropout related to density of drusen in human eyes with early age-related macular degeneration. Invest Ophthalmol Vis Sci, 2011, 52(3): 1606–1612
Machalinska A, Safranow K, Dziedziejko V, et al. Different populations of circulating endothelial cells in patients with age-related macular degeneration: a novel insight into pathogenesis. Invest Ophthalmol Vis Sci, 2011, 52(1):93–100
Machalinska A, Safranow K, Sylwestrzak Z, et al. Elevated level of circulating endothelial cells as an exponent of chronic vascular dysfunction in the course of AMD. Klin Oczna, 2011, 113(7–9):228–232
Gustavsson C, Agardh CD, Zetterqvist AV, et al. Vascular cellular adhesion molecule-1 (VCAM-1) expression in mice retinal vessels is affected by both hyperglycemia and hyperlipidemia. PLoS One, 2010, 5(9):e12699
Mullins RF, Skeie JM, Malone EA, et al. Macular and peripheral distribution of ICAM-1 in the human choriocapillaris and retina. Mol Vis, 2006, 30(12):224–235
Boltz A, Luksch A, Wimpissinger B, et al. Choroidal blood flow and progression of age-related macular degeneration in the fellow eye in patients with unilateral choroidal neovascularization. Invest Ophthalmol Vis Sci, 2010, 51(8):4220–4425
Berenberg TL, Metelitsina TI, Madow B, et al. The association between drusen extent and foveolar choroidal blood flow in age-related macular degeneration. Retina, 2012, 32(1):25
Ng HH, Zhang Y, Hendrich B, et al. MBD2 is a transcriptional repressor belonging to the MeCP1 histone deacetylase complex. Nat Genet, 1999, 23(1):58–61
Fatemi M, Wade PA. MBD family proteins: reading the epigenetic code. J Cell Sci, 2006, 119(Pt 15): 3033–3037
Kanda A, Abecasis G, Swaroop A, et al. Inflammation in the pathogenesis of age-related macular degeneration. Br J Ophthalmol, 2008, 92(4):448–450
Xu H, Chen M, Forrester JV, et al. Para-inflammation in the aging retina. Prog Retin Eye Res, 2009, 28(5): 348–368
Frank PG, Lisanti MP. ICAM-1: role in inflammation and in the regulation of vascular permeability. Am J Physiol Heart Circ Physiol, 2008, 295(3):H926–H927
Lawson C, Wolf S. ICAM-1 signaling in endothelial cells. Pharmacol Rep, 2009, 61(1):22–32
Penfold PL, Wen L, Madigan MC, et al. Modulation of permeability and adhesion molecule expression by human choroidal endothelial cells. Invest Ophthalmol Vis Sci, 2002, 43(9):3125–3130
Hafezi-Moghadam A. In: Joyce Tombran-Tink, Colin J. Barnstable, Thomas W, eds. Visual Dysfunction in Diabetes. New York: Springer, 2012:105–122
Skeie JM, Fingert JH, Russell SR, et al. Complement component C5a activates ICAM-1 expression on human choroidal endothelial cells. Invest Ophthalmol Vis Sci, 2010, 51(10):5336–5342
Author information
Authors and Affiliations
Corresponding author
Additional information
This study was supported by grants from Natural Science Foundation of Hubei Province (No: 2012FFB02304) and Scientific Research Foundation of Ministry of Education (No: 2013-1792), China.
Rights and permissions
About this article
Cite this article
Pan, Jr., Wang, C., Yu, Ql. et al. Effect of Methyl-CpG binding domain protein 2 (MBD2) on AMD-like lesions in ApoE-deficient mice. J. Huazhong Univ. Sci. Technol. [Med. Sci.] 34, 408–414 (2014). https://doi.org/10.1007/s11596-014-1292-2
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11596-014-1292-2